Monogram Technologies (Nasdaq:MGRM) announced today that it received FDA 510(k) clearance for its mBôs total knee ...

为探究单髁膝关节置换术（UKA）转 TKA 翻修术后髌骨高度变化，研究发现总体变化无临床意义，需长期研究。 在医学领域，如果单髁膝关节置换术（unicompartmental knee arthroplasty，UKA）需要翻修，将其转换为全膝关节置换术（total knee arthroplasty，TKA）仍是常用方法。

On Monday, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for Monogram Technologies Inc.’s (NASDAQ:MGRM ...

“There is a lot of literature that has shown that same-day discharge from a freestanding center for hip and knee arthroplasty is safe and predictable,” Dr. Bolognesi told OTW. “Our intent is not to ...

At this year's American Academy of Orthopedic Surgeons (AAOS) annual meeting, investigators at Hospital for Special Surgery ...

Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors ...

Monogram Orthopaedics Inc ( ($MGRM) ) has issued an update. On March 17, 2025, Monogram Technologies Inc. announced that it received FDA 510(k) ...

Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act).

What follows are highlights from these studies: Limiting Use of Tourniquets During Knee Replacement Surgery Improves Patient Outcomes Tourniquets have traditionally been used during TKA to reduce ...